Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier

doi:10.1172/JCI118598

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

K Brand, S Page, G Rogler, A Bartsch, R Brandl, R Knuechel, M Page, C Kaltschmidt, P A Baeuerle, and D Neumeier

Published April 1, 1996 - More info

View PDF

Abstract

Nuclear factor-kappa B (NF-kappaB)/Rel transcription factors play an important role in the inducible regulation of a variety of genes involved in the inflammatory and proliferative responses of cells. The present study was designed to elucidate the implication of NF-kappaB/Rel in the pathogenesis of atherosclerosis. Activation of the dimeric NF-kappaB complex is regulated at a posttranslational level and requires the release of the inhibitor protein IkappaB. The newly developed mAb alpha-p65mAb recognizes the IkappaB binding region on the p65 (RelA) DNA binding subunit and therefore selectively reacts with p65 in activated NF-kappaB. Using immunofluorescence and immunohistochemical techniques, activated NF-kappaB was detected in the fibrotic-thickened intima/media and atheromatous areas of the atherosclerotic lesion. Activation of NF-kappaB was identified in smooth muscle cells, macrophages, and endothelial cells. Little or no activated NF-kappaB was detected in vessels lacking atherosclerosis. Electrophoretic mobility shift assays and colocalization of activated NF-kappaB with NF-kappaB target gene expression suggest functional implications for this transcription factor in the atherosclerotic lesion. This study demonstrates the presence of activated NF-kappaB in human atherosclerotic tissue for the first time. Atherosclerosis, characterized by features of chronic inflammation and proliferative processes, may be a paradigm for the involvement of NF-kappaB/Rel in chronic inflammatory disease.

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

K Brand, S Page, G Rogler, A Bartsch, R Brandl, R Knuechel, M Page, C Kaltschmidt, P A Baeuerle, and D Neumeier

Article tools

Metrics

Go to

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

K Brand, S Page, G Rogler, A Bartsch, R Brandl, R Knuechel, M Page, C Kaltschmidt, P A Baeuerle, and D Neumeier

Article tools

Metrics

Go to

Sign up for email alerts